DE3851577D1 - Hexacyclische Verbindungen. - Google Patents

Hexacyclische Verbindungen.

Info

Publication number
DE3851577D1
DE3851577D1 DE3851577T DE3851577T DE3851577D1 DE 3851577 D1 DE3851577 D1 DE 3851577D1 DE 3851577 T DE3851577 T DE 3851577T DE 3851577 T DE3851577 T DE 3851577T DE 3851577 D1 DE3851577 D1 DE 3851577D1
Authority
DE
Germany
Prior art keywords
compound
hexacyclic compounds
antitumour
camptothecin
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3851577T
Other languages
English (en)
Other versions
DE3851577T2 (de
Inventor
Hiroaki C O Daiichi Sei Tagawa
Masamichi C O Daiichi Sugimori
Hirofumi C O Daiichi Terasawa
Akio C O Daiichi Seiyaku Ejima
Satoru C O Daiichi Seiy Ohsuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd, Yakult Honsha Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3851577D1 publication Critical patent/DE3851577D1/de
Publication of DE3851577T2 publication Critical patent/DE3851577T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
  • Liquid Crystal Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE3851577T 1987-06-24 1988-06-23 Hexacyclische Verbindungen. Expired - Fee Related DE3851577T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15699087 1987-06-24
JP550388 1988-01-13

Publications (2)

Publication Number Publication Date
DE3851577D1 true DE3851577D1 (de) 1994-10-27
DE3851577T2 DE3851577T2 (de) 1995-04-27

Family

ID=26339454

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3851577T Expired - Fee Related DE3851577T2 (de) 1987-06-24 1988-06-23 Hexacyclische Verbindungen.

Country Status (13)

Country Link
US (2) US4939255A (de)
EP (1) EP0296597B1 (de)
KR (1) KR960002853B1 (de)
AT (1) ATE111913T1 (de)
AU (1) AU610189B2 (de)
CA (1) CA1304370C (de)
DE (1) DE3851577T2 (de)
DK (1) DK344488A (de)
ES (1) ES2064329T3 (de)
FI (1) FI91872C (de)
IE (1) IE61281B1 (de)
NO (1) NO167738C (de)
PH (1) PH27557A (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5658920A (en) * 1991-01-16 1997-08-19 Daiichi Pharmaceutical Co., Ltd. Substituted 1H,12H-benz-[DE]pyrano[3',4':6,7] indolizino[1,2-B]quinoline-10,13(9H,15H)-dione compound
US6407115B1 (en) * 1991-01-16 2002-06-18 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic compound
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
US5446047A (en) * 1992-07-23 1995-08-29 Sloan-Kettering Institute For Cancer Research Camptothecin analogues
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5670500A (en) * 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
WO1996040886A1 (en) * 1995-06-07 1996-12-19 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
TW464652B (en) * 1996-10-30 2001-11-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
KR19980076076A (ko) * 1997-04-04 1998-11-16 유현식 전선용 발포성 수지조성물
US6046209A (en) * 1997-05-27 2000-04-04 Smithkline Beecham Corporation Water soluble camptothecin analogs
IN189180B (de) 1997-07-09 2003-01-04 Chong Kun Dang Corp
JP4094710B2 (ja) 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体
EP1229934B1 (de) 1999-10-01 2014-03-05 Immunogen, Inc. Zusammensetzungen und verfahren zur behandlung von krebs mittels immunkonjugaten und chemotherapeutischen agenzien
FR2801309B1 (fr) * 1999-11-18 2002-01-04 Adir Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4305909B2 (ja) 2001-11-30 2009-07-29 中外製薬株式会社 六環式化合物
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
WO2004073601A2 (en) * 2003-02-21 2004-09-02 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of hexacyclic camptothecin derivatives
CN1964979B (zh) 2004-04-09 2011-07-27 中外制药株式会社 新颖的水溶性前药
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
CN102060713A (zh) * 2010-12-09 2011-05-18 中华人民共和国嘉兴出入境检验检疫局 用于检测偶氮类染料的芳香胺半抗原及其制备方法
WO2020200880A1 (en) 2019-03-29 2020-10-08 Medimmune Limited Compounds and conjugates thereof
TW202140076A (zh) 2020-01-22 2021-11-01 英商梅迪繆思有限公司 化合物及其軛合物
KR20220130749A (ko) 2020-01-22 2022-09-27 메디뮨 리미티드 화합물 및 이의 접합체
US11806405B1 (en) 2021-07-19 2023-11-07 Zeno Management, Inc. Immunoconjugates and methods
WO2023180485A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing trop-2
WO2023180489A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing carcinoembyronic antigen
WO2023180490A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing nectin-4
WO2023180484A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing ptk7

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32518A (en) * 1861-06-11 Improvement in city railroads
JPS51288A (ja) * 1974-06-18 1976-01-05 Tamura Seisakusho Kk Hanshakyoshinhoshasochi
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS5839685A (ja) * 1981-09-04 1983-03-08 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体及びその製造法
US4473692A (en) * 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
EP0220601B1 (de) * 1985-10-21 1991-12-11 Daiichi Seiyaku Co., Ltd. Pyranoindolizinderivate und Verfahren zu ihrer Herstellung
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体

Also Published As

Publication number Publication date
NO882785L (no) 1988-12-27
ATE111913T1 (de) 1994-10-15
EP0296597A3 (de) 1991-07-31
DE3851577T2 (de) 1995-04-27
NO167738B (no) 1991-08-26
DK344488D0 (da) 1988-06-23
PH27557A (en) 1993-08-18
IE61281B1 (en) 1994-10-19
US4939255A (en) 1990-07-03
FI91872C (fi) 1994-08-25
ES2064329T3 (es) 1995-02-01
AU1834988A (en) 1989-01-05
EP0296597A2 (de) 1988-12-28
KR890000489A (ko) 1989-03-15
AU610189B2 (en) 1991-05-16
FI883050A (fi) 1988-12-25
EP0296597B1 (de) 1994-09-21
FI91872B (fi) 1994-05-13
DK344488A (da) 1989-02-24
NO882785D0 (no) 1988-06-23
FI883050A0 (fi) 1988-06-23
US5061795A (en) 1991-10-29
IE881860L (en) 1988-12-24
KR960002853B1 (ko) 1996-02-27
NO167738C (no) 1991-12-04
CA1304370C (en) 1992-06-30

Similar Documents

Publication Publication Date Title
ATE111913T1 (de) Hexacyclische verbindungen.
ATE138661T1 (de) Hexacyclische verbindungen
NO2002009I2 (no) Tiotropium
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
ES2147749T3 (es) Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
FI891866A (fi) Menetelmä terapeuttisesti käyttökelpoisten sulfonanilidien valmistamiseksi
NO180633C (no) Fremgangsmåte for fremstilling av oxazolinforbindelser
EP0357109A3 (en) Platinum-(ii)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action which contains this compound and also shaped preparations with an anti-tumour action
DK165166C (da) Vandige injicerbare oxytetracyclinoploesninger indeholdende polyvinylpyrrolidon og en magnesiumforbindelse samt fremgangsmaade til fremstilling deraf
JPS57158754A (en) Improvement on organic compounds
DK0412464T3 (da) Butalactin, en fremgangsmåde til dets fremstilling og dets anvendelse som lægemiddel
EP0307226B1 (en) Process for the preparation of a macrolide compound

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee